Abstract:Scale-up production technology of highly purified bacillomycin D was established to support the exploration for its agriculturally antibiotic activity. After isolation, purification and molecular identification, the bioactive compounds extracted from Bacillus amyloliquefaciens TYg 3-2 were identified as antibiotic lipopeptides bacillomycin D. The refined nature media and chemically defined available carbon and nitrogen sources, including yeast extract, peptone, glucose, and (NH4)2SO4, were combined and optimized using response surface method for high-yield complex medium of bacillomycin D. Using the optimized medium, the yield of bacillomycin D in 5 L bioreactor reached 990 mg/L. The productivity reached 20.62 mg/(L·h), which was much higher than the previously reported productivity of 10.23 mg/(L·h). Biomass-supernatant separation, acid precipitation, methanol extraction, Et2O precipitation, macroporous absorption resin column chromatography and silica gel column chromatography were conducted for efficient purification of bacillomycin D. And 94.72%purity was obtained when high-quality raw material was used. Preliminary exploration for antibiotic activity was conducted using the highly purified bacillomycin D sample. Inhibition tests in vitro demonstrated that bacillomycin D was the main effective substance against Drechslera turcica, Curvularia lunata, Ustilaginoidea virens and Alternaria longipes in vitro. And the result of pot test in vivo revealed that bacillomycin D was the promotor on biocontrol efficacy of homologous B. amyloliquefaciens TYg 3-2 biomass. Because the mixture of 500 mg/L bacillomycin D and 4 × 106 CFU/mL B. amyloliquefaciens TYg 3-2 biomass exhibited 95.3% biocontrol efficacy against Colletotrichum orbiculare in vivo, which was higher than those of bacillomycin D alone (78.4%) and Bacillus biomass alone (0). The potential value of bacillomycin D in the field of agricultural antibiotic was preliminarily explored. And scale-up production technology of highly purified lipopeptides played an important role in this exploration. Not only could it isolate and purify target lipopeptide from fermentation broth for this agricultural antibiotic research without the loss in producing bacteria (the spore of which was the feedstock of biocontrol agent), but also can it satisfy the requirement of toxicological tests of pesticide registration in China (sample with >85% purity in grams). As a result, this research was able to support the research and development of agriculturally antibiotic value in Bacillus lipopeptides.

Novel Activity Evaluation and Subsequent Partial Purification of Antimicrobial Peptides Produced by Bacillus Subtilis Lfb112

Isolation and Partial Characterization of Antibiotics Produced by Paenibacillus Elgii B69.

A comparison of mining methods to extract novel bacteriocins from Lactiplantibacillus plantarum NWAFU-BIO-BS29

Isolation and identification of lipopeptide antibiotics from Paenibacillus elgii B69 with inhibitory activity against methicillin-resistant Staphylococcus aureus

Optimization of Fermentation Medium for Production of Antibacterial Peptides by Bacillus Subtilis BSD-2

Two Antimicrobial Peptides Derived from Bacillus and Their Properties

Anti-listerial peptides from a marine Bacillus velezensis FTL7: production optimization, characterizations and molecular docking studies

Expression and Purification of an Antimicrobial Peptide, Bovine Lactoferricin Derivative LfcinB-W10 in Escherichia Coli

Expression, Purification, and Characterization of a Novel Hybrid Peptide with Potent Antibacterial Activity.

Recombinant expression, purification, and antimicrobial activity of a novel hybrid antimicrobial peptide LFT33

Purification and characterization of a novel low-molecular-weight antimicrobial peptide produced by Lactiplantibacillus plantarum NMGL2

Identification and characterization of antibacterial peptides produced by Lactobacillus plantarum 1407

Purification and antimicrobial mechanism of a novel bacteriocin produced by Lactobacillus rhamnosus 1.0320

Isolation and Characterization of A Bacteriocin Produced by an Isolated Bacillus Subtilis Lfb112 That Exhibits Antimicrobial Activity Against Domestic Animal Pathogens

Design and high-level expression of a hybrid antimicrobial peptide LF15-CA8 in Escherichia coli

Characterization of the broad-spectrum antibacterial activity of bacteriocin-like inhibitory substance-producing probiotics isolated from fermented foods

Purification and characterization of bacteriocin produced by a strain of Lacticaseibacillus rhamnosus ZFM216

Fermentation and Purification Optimizations of Bacillomycin D , and Preliminary Exploration for Its Antibiotic Activity

Isolation and characterization of peptide antibiotics LI-F04 and polymyxin B6 produced by Paenibacillus polymyxa strain JSa-9

Expression, Purification and Characterization of a Novel Hybrid Peptide CLP with Excellent Antibacterial Activity

Identification of A New Bacillus Licheniformis Strain Producing A Bacteriocin-Like Substance